Sercan Yılmaz1, Engin Kaya1, Eymen Gazel2, Serdar Yalcın1, Halil Cagrı Aybal3, Mehmet Yılmaz4, Onur Açıkgöz5, Hakan Özdemir6, Lutfi Tunc7. 1. Department of Urology, Gulhane Training and Research Hospital, Health Sciences University, Ankara, Turkey. 2. Department of Urology, Acıbadem University Ankara Hospital, Ankara, Turkey. 3. Department of Urology, Kahramankazan Hamdi Eris State Hospital, Ankara, Turkey. 4. Department of Urology, Zile State Hospital, Kahya Mahallesi Ata Caddesi No: 1 Zile, 60400, Tokat, Turkey. yilmazmehmet88@hotmail.com. 5. Department of Urology, Pendik State Hospital, Istanbul, Turkey. 6. Department of Radiology, Diason Ultrasonography Center, Ankara, Turkey. 7. Department of Urology, Gazi University School of Medicine, Ankara, Turkey.
Abstract
PURPOSE: Holmium laser enucleation of the prostate (HoLEP) has recently become the recommended treatment for prostate in all sizes in benign prostate hyperplasia surgery. A recent prostate biopsy performed prior to the HoLEP procedure can make surgeons concerned about the surgery. We aimed to investigate the per- and postoperative outcomes of the HoLEP procedure in patients who underwent prostate biopsy and to evaluate the most appropriate surgery time after biopsy. METHODS: The data of 160 patients who underwent HoLEP by a single surgeon between March 2017 and December 2019 were retrospectively reviewed. The patients were divided into two groups, Group 1 consisted of 80 patients without prostate biopsy and Group 2 consisted of 80 patients with prior prostate biopsy. All HOLEP procedures in group 2 were performed at least 2 weeks following biopsy. Per- and postoperative outcomes, complications were evaluated. RESULTS: No significant differences were found between groups in terms of by enucleation time, efficiency of laser, efficiency of enucleation, hospitalization time, and catheterization removal time. Only morcellation time was shorter in biopsy naïve patients. There were no statistical differences in postoperative outcomes. Previous prostate biopsy did not affect the continence status in our study group. There were not any Clavien grade 4 or higher complications. Urinary tract infection was higher in early post-biopsy period, there was no difference among the groups. CONCLUSıON: Our study confirms that HoLEP is a safe and efficient surgical procedure for the patients with prior prostate biopsy. We believe that it can be safely performed 2nd week following prostate biopsy.
PURPOSE: Holmium laser enucleation of the prostate (HoLEP) has recently become the recommended treatment for prostate in all sizes in benign prostate hyperplasia surgery. A recent prostate biopsy performed prior to the HoLEP procedure can make surgeons concerned about the surgery. We aimed to investigate the per- and postoperative outcomes of the HoLEP procedure in patients who underwent prostate biopsy and to evaluate the most appropriate surgery time after biopsy. METHODS: The data of 160 patients who underwent HoLEP by a single surgeon between March 2017 and December 2019 were retrospectively reviewed. The patients were divided into two groups, Group 1 consisted of 80 patients without prostate biopsy and Group 2 consisted of 80 patients with prior prostate biopsy. All HOLEP procedures in group 2 were performed at least 2 weeks following biopsy. Per- and postoperative outcomes, complications were evaluated. RESULTS: No significant differences were found between groups in terms of by enucleation time, efficiency of laser, efficiency of enucleation, hospitalization time, and catheterization removal time. Only morcellation time was shorter in biopsy naïve patients. There were no statistical differences in postoperative outcomes. Previous prostate biopsy did not affect the continence status in our study group. There were not any Clavien grade 4 or higher complications. Urinary tract infection was higher in early post-biopsy period, there was no difference among the groups. CONCLUSıON: Our study confirms that HoLEP is a safe and efficient surgical procedure for the patients with prior prostate biopsy. We believe that it can be safely performed 2nd week following prostate biopsy.
Authors: Eymen Gazel; Engin Kaya; Serdar Yalcin; Halil Çagri Aybal; Tahsin Batuhan Aydogan; Lutfi Tunc Journal: Urol Int Date: 2019-02-07 Impact factor: 2.089
Authors: Annika Herlemann; Kerstin Wegner; Alexander Roosen; Alexander Buchner; Philipp Weinhold; Alexander Bachmann; Christian G Stief; Christian Gratzke; Giuseppe Magistro Journal: World J Urol Date: 2017-05-17 Impact factor: 4.226
Authors: Harris E Foster; Philipp Dahm; Tobias S Kohler; Lori B Lerner; J Kellogg Parsons; Timothy J Wilt; Kevin T McVary Journal: J Urol Date: 2019-08-08 Impact factor: 7.450
Authors: Louise Dickinson; Hashim U Ahmed; Clare Allen; Jelle O Barentsz; Brendan Carey; Jurgen J Futterer; Stijn W Heijmink; Peter J Hoskin; Alex Kirkham; Anwar R Padhani; Raj Persad; Philippe Puech; Shonit Punwani; Aslam S Sohaib; Bertrand Tombal; Arnauld Villers; Jan van der Meulen; Mark Emberton Journal: Eur Urol Date: 2010-12-21 Impact factor: 20.096
Authors: Sercan Yılmaz; Engin Kaya; Eymen Gazel; Serdar Yalcın; Halil Cagrı Aybal; Mehmet Yılmaz; Onur Açıkgöz; Hakan Özdemir; Lutfi Tunc Journal: World J Urol Date: 2020-11-13 Impact factor: 4.226
Authors: Sercan Yılmaz; Engin Kaya; Eymen Gazel; Serdar Yalcın; Halil Cagrı Aybal; Mehmet Yılmaz; Onur Açıkgöz; Hakan Özdemir; Lutfi Tunc Journal: World J Urol Date: 2020-11-13 Impact factor: 4.226